When the performance of AI models was assessed within stratified patient subgroups, such as only high-grade breast cancers or only MSI-positive tumors, accuracy fell substantially, revealing that the ...
Elacestrant combinations in patients (pts) with ER+/HER2- locally advanced or metastatic breast cancer (mBC): Safety update from ELEVATE, a phase (Ph) 1b/2, open-label, umbrella study. This is an ASCO ...
Traditional task-specific computational pathology models require a substantial labeled dataset for training to perform various tasks, while foundation models can be trained on large-scale, unlabeled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results